FOMX
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
FOMX
Delisted
FOMX was delisted on the 6th of March, 2020.
56 hedge funds and large institutions have $110M invested in Foamix Pharmaceuticals Ltd. Ordinary Shares in 2018 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
15% less capital invested
Capital invested by funds: $130M → $110M (-$19.9M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
56
Holding in Top 10
1
Calls
$833K
Puts
$904K
Top Buyers
| 1 | +$5.64M | |
| 2 | +$888K | |
| 3 | +$666K | |
| 4 |
Barclays
London,
United Kingdom
|
+$568K |
| 5 |
EP
Eversept Partners
New York
|
+$551K |
Top Sellers
| 1 | -$4.45M | |
| 2 | -$2.27M | |
| 3 | -$1.91M | |
| 4 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$1.64M |
| 5 |
SCM
Sio Capital Management
New York
|
-$789K |